Efficacy and toxicity of drugs targeting KRAS < sup > G12C < /sup > mutation in non-small cell lung cancer: a meta-analysis
CONCLUSION: Sotorasib, Adagrasib, and Garsorasib as the drugs of choice for patients with KRASG12C mutation NSCLC, have definite efficacy and acceptable safety, especially for patients with advanced or metastatic disease and within posterior line therapy.PMID:37950424 | DOI:10.1080/14737140.2023.2282606 (Source: Expert Review of Anticancer Therapy)
Source: Expert Review of Anticancer Therapy - November 11, 2023 Category: Cancer & Oncology Authors: Wei Luo Jing Zhu Wenxue Zhang Airu Yu Wei Zhou Ke Xu Source Type: research

Prognostic value of circulating long non-coding RNAs in colorectal cancer patients: a meta-analysis
CONCLUSION: Circulating lncRNAs show promise as prognostic markers for CRC patients. However, further studies are warranted to validate these findings, given the limited number and representativeness of articles included in this study.PMID:37934874 | DOI:10.1080/14737140.2023.2280643 (Source: Expert Review of Anticancer Therapy)
Source: Expert Review of Anticancer Therapy - November 7, 2023 Category: Cancer & Oncology Authors: Bin Hu Yanfei Zhang Bingjing Jiang Angcheng Li Source Type: research

Immune checkpoint inhibitors in advanced cutaneous melanoma: a systematic review and meta-analysis of efficacy and review of characteristics
CONCLUSION: Our results suggest that ICI-based immunotherapy is associated with enhanced OS, PFS, and RFS (P < 0.001) and will assist clinicians in choosing the optimal approach toward treating metastatic melanoma.PMID:37908134 | DOI:10.1080/14737140.2023.2278509 (Source: Expert Review of Anticancer Therapy)
Source: Expert Review of Anticancer Therapy - November 1, 2023 Category: Cancer & Oncology Authors: Sara Mahdiabadi Sara Momtazmanesh Amirali Karimi Nima Rezaei Source Type: research